IBDEI1UB ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30811,0)
 ;;=R60.0^^135^1384^64
 ;;^UTILITY(U,$J,358.3,30811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30811,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,30811,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,30811,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,30812,0)
 ;;=R60.1^^135^1384^63
 ;;^UTILITY(U,$J,358.3,30812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30812,1,3,0)
 ;;=3^Edema,Generalized
 ;;^UTILITY(U,$J,358.3,30812,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,30812,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,30813,0)
 ;;=R60.9^^135^1384^65
 ;;^UTILITY(U,$J,358.3,30813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30813,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,30813,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,30813,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,30814,0)
 ;;=R61.^^135^1384^85
 ;;^UTILITY(U,$J,358.3,30814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30814,1,3,0)
 ;;=3^Hyperhidrosis,Generalized
 ;;^UTILITY(U,$J,358.3,30814,1,4,0)
 ;;=4^R61.
 ;;^UTILITY(U,$J,358.3,30814,2)
 ;;=^331970
 ;;^UTILITY(U,$J,358.3,30815,0)
 ;;=R63.0^^135^1384^36
 ;;^UTILITY(U,$J,358.3,30815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30815,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,30815,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,30815,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,30816,0)
 ;;=R63.1^^135^1384^138
 ;;^UTILITY(U,$J,358.3,30816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30816,1,3,0)
 ;;=3^Polydipsia
 ;;^UTILITY(U,$J,358.3,30816,1,4,0)
 ;;=4^R63.1
 ;;^UTILITY(U,$J,358.3,30816,2)
 ;;=^186699
 ;;^UTILITY(U,$J,358.3,30817,0)
 ;;=R63.2^^135^1384^139
 ;;^UTILITY(U,$J,358.3,30817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30817,1,3,0)
 ;;=3^Polyphagia
 ;;^UTILITY(U,$J,358.3,30817,1,4,0)
 ;;=4^R63.2
 ;;^UTILITY(U,$J,358.3,30817,2)
 ;;=^5019540
 ;;^UTILITY(U,$J,358.3,30818,0)
 ;;=R63.3^^135^1384^72
 ;;^UTILITY(U,$J,358.3,30818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30818,1,3,0)
 ;;=3^Feeding Difficulties
 ;;^UTILITY(U,$J,358.3,30818,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,30818,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,30819,0)
 ;;=R63.4^^135^1384^29
 ;;^UTILITY(U,$J,358.3,30819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30819,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,30819,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,30819,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,30820,0)
 ;;=R63.5^^135^1384^28
 ;;^UTILITY(U,$J,358.3,30820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30820,1,3,0)
 ;;=3^Abnormal Weight Gain
 ;;^UTILITY(U,$J,358.3,30820,1,4,0)
 ;;=4^R63.5
 ;;^UTILITY(U,$J,358.3,30820,2)
 ;;=^5019543
 ;;^UTILITY(U,$J,358.3,30821,0)
 ;;=R64.^^135^1384^46
 ;;^UTILITY(U,$J,358.3,30821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30821,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,30821,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,30821,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,30822,0)
 ;;=R68.3^^135^1384^51
 ;;^UTILITY(U,$J,358.3,30822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30822,1,3,0)
 ;;=3^Clubbing of Fingers
 ;;^UTILITY(U,$J,358.3,30822,1,4,0)
 ;;=4^R68.3
 ;;^UTILITY(U,$J,358.3,30822,2)
 ;;=^5019553
 ;;^UTILITY(U,$J,358.3,30823,0)
 ;;=R73.01^^135^1384^89
 ;;^UTILITY(U,$J,358.3,30823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30823,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,30823,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,30823,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,30824,0)
 ;;=R73.02^^135^1384^90
 ;;^UTILITY(U,$J,358.3,30824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30824,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,30824,1,4,0)
 ;;=4^R73.02
